Replies to post #16048 on Cytodyn Inc (CYDY)

[trding]

Ibalizumab will initially be administered by IV once every two weeks but should be available in an intramuscular injection form about 12-15 months from approval.

That will be great for the patients and great for the drug, IV is holding it back some IMO.

My guess is the data will look good but the financing issue should keep everyone here very nervous.

Once we get the good data, I feel confident that financing will be an issue of the past.



Ibalizumbab has had a great stock price run as enrollment was announced, data was released, etc. Now it's pro 140's turn.

[benjiboyy]

Hey Fred

Thank you for this very informative answer and your effort to do so.
How long does it take for IV to be administered in comparison to a regular injection?

[The Lawman]

Ibalilzumab is IV only, requires a hospital visit, and is only being tested for salvage patients where nothing else works. In addition, unlike PRO 140, which has no toxicities, Ibalilzumab has many serious side effects.

As for the Phase II combo trial, my guess is that results will be announced sometime during the second half of July.

Phase III mono trial has 100 patients, and my guess is they will announce results by YE 2017.

Tony C recently put up $1M of his own money into the latest private placement, and directors Dockery and Naydenov have invested millions of their own dollars as well.

Insiders don't invest their own money unless they are confident in the company's success, and CYDY insiders know far more than anyone on this board as to the future prospects for the this company.